Second Sight Medical Products
Why Robinhood?
You can watch EYES and buy or sell other stocks, ETFs, and their options commission-free!About EYES
Second Sight Medical Products, Inc. engages in the development, manufacture, and marketing of implantable visual prosthetics. Its product, the Argus II Retinal Prosthesis System, treats outer retinal degenerations, such as retinitis pigmentosa, also referred to as RP.
EYES Key Statistics
Stock Snapshot
As of today, Second Sight Medical Products(EYES) shares are valued at $4.14. The company's market cap stands at 515.84M, with a P/E ratio of 0.00 and a dividend yield of 0.0%.
Second Sight Medical Products(EYES) stock opened on 2026-04-03 at —. The price climbed to — and dipped to —.
The Second Sight Medical Products(EYES)'s current trading volume is 0, compared to an average daily volume of 297.74K.
In the last year, Second Sight Medical Products(EYES) shares hit a 52-week high of $1.20 and a 52-week low of $0.64.
In the last year, Second Sight Medical Products(EYES) shares hit a 52-week high of $1.20 and a 52-week low of $0.64.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.